跳至主要内容
临床试验/NCT05542108
NCT05542108Enrolling By Invitation不适用

Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants

University of Pisa2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
24
试验地点
2
主要终点
General Movements (GM)

研究概览

简要总结

This project is a Randomised Clinical Trial that includes a tactile-kinesthetic somatosensory stimulation or family centred education intervention with families of preterm infants at risk for sensori-motor disorders.

This is a study will be based on the adaptation of the intervention previously described and published by Guzzetta and colleagues (2009), and will include an improved and increased kinesthetic component, to be performed in infants born very prematurely and preterm infants with a documented brain injury. The intervention will start in neonatology during the infant hospitalization and continue at the child's home until two months of correct age.

详细描述

Preterm babies, specifically with gestational age < 33+6 weeks, will be recruited and assigned (randomized) into an a Multisensory stimulation + Family Education Group (MSG) or a Family Education Only Group (FEG).

When the clinical condition of the child is stable and after a short training, parents of the MSG will be asked to carry out up to two treatment sessions per day with their child, until they reach the 8th post-term week. Sessions will initially be carried out together with a therapist who will have the task of transmitting the necessary skills to parents/caregivers. The therapist will assist parents through practical demonstrations, theoretical explanations and by answering the parents' questions.

The treatment will consist of sessions of approximately 25-30 minutes. The main purposes of the intervention will be clearly explained to the parents, and in particular the goal of maintaining a calm and natural interaction during the session.

In addition, all families will receive the evidence-based program of Family Education which is based on the promotion of the parent-child relationship through the recognition of behavioral states, methods of interaction, facilitation strategies in the relationship.

It takes its conceptual basis from the Mother Infant Transaction Program (MITP). It is a specific and re-adapted version for the preterm infant hospitalized in NICU

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Investigator and Outcomes assessors are blind to the group assignment of the infant. Care provider (Parents and Research staff supporting parents in intervention can not be masked to the group assignment).

入排标准

年龄范围
1 Week 至 10 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • premature infants born <29 weeks of gestation age or premature infants (born < 33+6 weeks gestation age) with a documented brain injury .

排除标准

  • Clinical instability, based on standard medical evaluation of preterm infants (eg: children with mechanical ventilation or under sedation)
  • Genetic-malformative conditions

结局指标

主要结局

General Movements (GM)

时间窗: 10-16 weeks corrected age

The quality of general movements (based on standard observation of infant movements) will be assessed

Electroencephalogram (EEG)

时间窗: 3 months corrected age

The EEG inter-burst interval, asymmetries and global and local spectral power will be analysed

次要结局

  • Developmental outcome assessment(12 months corrected age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Guzzetta

Full Professor

University of Pisa

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Tactile/kinesthetic Stimulus ProgramBreast Feeding, ExclusiveEnteral FeedingHospital Stay
NCT05486663Gonca Karatas Baran80
已完成
不适用
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)Peripheral Nerve InjuriesHand FracturesComplex Regional Pain Syndrome
NCT02070367Hamilton Health Sciences Corporation39
已完成
不适用
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerAccelerated Phase Chronic Myelogenous LeukemiaAngioimmunoblastic T-cell LymphomaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous LeukemiaBurkitt LymphomaChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous LeukemiaChildhood Diffuse Large Cell LymphomaChildhood Grade III Lymphomatoid GranulomatosisChildhood Immunoblastic Large Cell LymphomaChildhood Myelodysplastic SyndromesChildhood Nasal Type Extranodal NK/T-cell LymphomaChronic Neutrophilic LeukemiaChronic Phase Chronic Myelogenous LeukemiaChronic Eosinophilic LeukemiaContiguous Stage II Mantle Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtramedullary PlasmacytomaIntraocular LymphomaIsolated Plasmacytoma of BoneMeningeal Chronic Myelogenous LeukemiaEssential ThrombocythemiaNoncontiguous Stage II Mantle Cell LymphomaPrimary Systemic AmyloidosisProgressive Hairy Cell Leukemia, Initial TreatmentRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisProlymphocytic LeukemiaRecurrent Childhood Large Cell LymphomaRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Small Noncleaved Cell LymphomaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeRecurrent/Refractory Childhood Hodgkin LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Hairy Cell LeukemiaRefractory Multiple MyelomaRelapsing Chronic Myelogenous LeukemiaSecondary Acute Myeloid LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Childhood Anaplastic Large Cell LymphomaStage I Childhood Hodgkin LymphomaStage I Childhood Large Cell LymphomaStage I Childhood Lymphoblastic LymphomaStage I Childhood Small Noncleaved Cell LymphomaStage I Chronic Lymphocytic LeukemiaStage I Cutaneous T-cell Non-Hodgkin LymphomaStage I Multiple MyelomaStage I Mycosis Fungoides/Sezary SyndromeStage II Childhood Anaplastic Large Cell LymphomaStage II Childhood Hodgkin LymphomaStage II Childhood Large Cell LymphomaStage II Childhood Lymphoblastic LymphomaStage II Childhood Small Noncleaved Cell LymphomaStage II Chronic Lymphocytic LeukemiaStage II Cutaneous T-cell Non-Hodgkin LymphomaStage II Multiple MyelomaStage II Mycosis Fungoides/Sezary SyndromeStage III Childhood Anaplastic Large Cell LymphomaStage III Childhood Hodgkin LymphomaStage III Childhood Large Cell LymphomaStage III Childhood Lymphoblastic LymphomaStage III Childhood Small Noncleaved Cell LymphomaStage III Chronic Lymphocytic LeukemiaStage III Cutaneous T-cell Non-Hodgkin LymphomaStage III Multiple MyelomaStage III Mycosis Fungoides/Sezary SyndromeStage IV Childhood Anaplastic Large Cell LymphomaStage IV Childhood Hodgkin LymphomaStage IV Childhood Large Cell LymphomaStage IV Childhood Lymphoblastic LymphomaStage IV Childhood Small Noncleaved Cell LymphomaStage IV Chronic Lymphocytic LeukemiaStage IV Cutaneous T-cell Non-Hodgkin LymphomaStage IV Mycosis Fungoides/Sezary SyndromeT-cell Large Granular Lymphocyte LeukemiaUnspecified Childhood Solid Tumor, Protocol SpecificChronic Myelomonocytic LeukemiaPolycythemia VeraPrimary MyelofibrosisPost-transplant Lymphoproliferative DisorderAcute Undifferentiated LeukemiaJuvenile Myelomonocytic LeukemiaMast Cell Leukemia
NCT01053494Wake Forest University Health Sciences80
已完成
不适用
Sensory Stimulation to Enhance Hand Function Post StrokeStroke
NCT02675764Medical University of South Carolina12
Unknown
不适用
Neonatal Experience of Social TouchInfant DevelopmentPainPremature Birth
NCT05039918Liverpool John Moores University40